Spoken Alpha
Aclarion, Inc.
Aclarion provides software that uses magnetic resonance spectroscopy to identify which spinal discs are causing pain, helping surgeons plan better treatments for low back and neck pain patients.
Aclarion, Inc is a Healthcare company operating in Health Information Services with a $5.6M market cap.
ACON missed consensus EPS by 0.1% in Q2 FY2026, reported Aug 5, 2026.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-10-04.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add ACON, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ACON.
$ curl https://api.spokenalpha.com/v1/companies/ACONFAQ
Spoken Alpha indexes ACON's earnings call transcripts at https://spokenalpha.com/companies/ACON. Each call links to attributed speakers and parsed analyst Q&A. Aclarion, Inc.'s own investor relations page is at https://investors.aclarion.com/.
Aclarion, Inc. (ACON) operates in the Healthcare sector (Health Information Services industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | $-1.12 | $-1.05 | -6.7% | $25.2K | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $-1.34 | $-1.55 | +13.6% | $21.1K | — | — | EODHD |
| Q4 FY2025 | 2026-02-24 | $-4.52 | $-3.60 | -25.6% | $18.5K | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $-2.93 | $-2.64 | -11.0% | $18.9K | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-2.75 | $-2.26 | -21.7% | $19.3K | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-9.32 | $-1356.74 | +99.3% | $19.0K | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $-1628.09 | $-1356.74 | -20.0% | $10.2K | — | — | EODHD |
| Q3 FY2024 | 2024-11-13 | $-1356.74 | $-1628.09 | +16.7% | $14.4K | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-1356.74 | $-2080.33 | +34.8% | $11.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-3979.77 | $-5155.61 | +22.8% | $10.1K | — | — | EODHD |
| Q4 FY2023 | 2024-02-19 | $-1.53 | $-1.60 | +4.2% | $13.8K | — | — | EODHD |
| Q3 FY2023 | 2023-11-13 | $-17366.27 | $-13024.70 | -33.3% | $19.1K | — | — | EODHD |
| Q2 FY2023 | 2023-08-24 | $-26049.40 | $-13024.70 | -100.0% | $17.1K | — | — | EODHD |
| Q1 FY2023 | 2023-05-30 | $-0.10 | $-0.10 | 0.0% | $25.5K | — | — | EODHD |
| Q4 FY2022 | 2023-02-26 | $-14471.89 | $-23155.03 | +37.5% | $22.5K | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-30390.97 | $-17366.27 | -75.0% | $18.2K | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-70912.27 | $-15919.08 | -100.0% | $10.7K | — | — | EODHD |
| Q1 FY2022 | 2022-06-05 | $-1.35 | — | — | $9.0K | — | — | EODHD |
Source: EODHD. ACON reported actuals as published; sparse fields render as —.